News

TBVI Releases 2009 Annual Report

5 Jul 2010
by Working Group
TB News
vaccines

From the TBVI website: http://www.tbvi.eu/news-agenda/tbvi-news/news-message/tbvi-annual-report-2009-released.html

TBVI 2009 Annual Report
TBVI 2009 Annual Report

TuBerculosis Vaccine Initiative (TBVI), a foundation that aims to develop new vaccines for tuberculosis, today released its annual report 2009.

In 2009 TBVI made significant progress in its overall objective to develop new vaccines for tuberculosis. Preceded by many years of research and development, last year four vaccine candidates moved from discovery phase to early clinical development. Furthermore, TBVI expanded its network with several new research partners and completed the formation of its Board of Trustees.

Last year wealso successfully acquired new funding that has strengthened our organisation and secured continued support for R&D activities carried out by our partners.

The annual report gives a further overview of our advancements, our work and our partners.

Jelle Thole,
Director TBVI

More News
19 Mar 2024

Most Robust TB Drug Pipeline in History

For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...
3 Aug 2023

New Tools Summit in Paris this November

The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, is co-hosting a New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting will be...
23 Aug 2022

PAN-TB Collaboration Announces Novel TB Drug Regimens Trial

The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...